Ptc therapeutics, inc. (PTCT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Performance obligations satisfied in current period

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues:
Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

4,042

4,729

0

0

0

Revenue

321,656

306,980

296,859

279,034

262,255

264,734

256,426

244,688

223,907

194,392

141,553

122,686

90,357

82,705

70,248

57,038

48,179

36,766

36,689

28,607

23,510

25,245

16,999

31,594

36,771

34,696

37,480

28,776

0

0

0

Cost of Goods and Service, Excluding Amortization Of Intangible Assets

13,844

12,135

12,354

12,640

12,001

12,670

11,107

9,397

7,583

4,577

2,379

797

39

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Amortization of acquired intangible assets

29,500

27,700

25,772

24,572

23,572

22,900

22,512

26,428

20,828

15,400

9,716

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

294,993

257,452

229,267

220,559

193,187

171,984

147,572

123,228

121,456

117,456

114,233

115,605

113,597

117,633

126,670

125,914

125,277

121,816

113,639

101,764

91,887

79,838

67,987

63,108

59,507

54,875

50,321

48,354

0

0

0

Selling, general and administrative

220,206

202,541

187,709

176,793

161,123

153,548

140,364

133,419

128,740

121,271

109,961

102,192

96,692

97,130

98,845

96,559

90,403

82,080

74,210

63,372

54,895

44,820

34,287

30,436

28,298

25,219

21,518

18,004

0

0

0

Change in the fair value of deferred and contingent consideration

-28,100

-48,360

-55,300

-45,800

-40,500

-19,340

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

586,665

548,138

510,370

480,300

430,337

380,419

321,521

292,445

278,587

258,684

236,289

218,594

210,328

214,763

225,515

222,473

215,680

203,896

187,849

165,136

146,782

124,658

102,274

93,544

87,805

80,094

71,840

66,358

0

0

0

Loss from operations

-265,009

-241,158

-213,511

-201,266

-168,082

-115,685

-65,095

-47,757

-54,680

-64,292

-94,736

-95,908

-119,971

-132,058

-155,267

-165,435

-167,501

-167,130

-151,160

-136,529

-123,272

-99,413

-85,275

-61,950

-51,034

-45,398

-34,360

-37,582

0

0

0

Interest expense, net

-15,845

-12,491

-10,277

-10,729

-11,539

-12,554

-12,751

-13,054

-13,178

-12,094

-10,775

-9,487

-8,539

-8,276

-8,686

-7,405

-4,847

-2,367

577

1,783

1,533

1,180

938

611

249

-6,084

-6,496

-6,858

0

0

0

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Other expense, net

0

13,723

1,572

-494

-984

129

1,158

1,190

43

-1,279

-685

-2,237

-804

-1,207

-1,852

-1,117

-818

-465

-645

-629

-524

-213

-35

-37

-73

38

3

1,805

0

0

0

Loss before income tax expense

-280,854

-239,926

-222,216

-212,489

-180,605

-128,110

-76,688

-59,621

-67,815

-77,665

-106,196

-107,632

-129,314

-141,541

-165,805

-173,957

-173,166

-169,962

-146,548

-128,517

0

-

0

0

-

-

-

-

-

-

-

Income tax expense

11,296

11,650

12

711

326

-29

1,794

1,630

1,391

1,335

870

863

620

569

293

254

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-292,150

-251,576

-222,228

-213,200

-180,931

-128,081

-78,482

-61,251

-69,206

-79,000

0

0

0

-

-

-

-

-

-

-

-

-

-84,372

-61,506

-50,988

-51,574

-40,983

-42,635

0

0

0

Deemed dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,249

0

0

0

-

-

Gain on exchange of convertible preferred stock in connection with recapitalization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,391

163,345

0

0

-

0

Less beneficial conversion charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-166,262

-174,318

-173,765

-

0

0

0

-

-

-

-

-66,432

-55,841

102,083

0

0

0

Basic net income (loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,605.53

-

Diluted net income (loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,605.53

-

Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Basic and Diluted

62,389

67,221

56,463

55,912

55,855

50,444

48,096

46,137

41,626

41,507

41,296

39,621

34,305

34,170

34,088

34,000

33,919

33,927

33,908

33,600

33,067

43,084

29,351

29,332

24,492

24,861

23,803

2,648

4

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

3

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

10

Earnings Per Share [Abstract]
Earnings Per Share, Basic and Diluted

-1.81

-1.17

-1.06

-0.75

-1.29

-1.02

-1.06

-0.21

-0.46

0.09

-0.82

-0.44

-0.85

-0.78

-1.03

-1.14

-1.22

-1.51

-1.27

-1.14

-1.15

-0.60

-0.93

-0.86

-0.58

6,527.82

-0.19

-5.51

-6,527.30

-

-

Net income (loss) per share applicable to common stockholders-basic (unaudited)(in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

168.00

Net income (loss) per share applicable to common stockholders-diluted (unaudited)(in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48.29

Product [Member]
Revenue

306,448

291,306

295,732

277,384

260,078

263,005

0

0

0

-

-

-

89,011

81,447

69,022

56,781

47,505

33,696

21,083

0

0

-

0

-

-

-

-

-

-

-

-

Collaboration and grant revenue
Revenue

15,208

15,674

1,192

1,718

0

-

0

0

-

-

-

-

1,346

1,258

1,226

257

674

3,070

16,277

16,989

17,794

24,528

18,582

33,321

37,771

34,696

33,437

24,047

0

0

0